• "One of the nation's premier plaintiffs' firms."

    American Lawyer
  • "Representing the best qualities of the plaintiffs' bar."

    The National Law Journal
  • "Their effective and caring advocacy for clients has earned Lieff Cabraser its first-class reputation."

    The Daily Journal
  • NLJ Hot List icon
  • U.S. News Best Lawyers badge 2011-2012
  • Super Lawyers Nationwide
  •  
    Visit us on Facebook
    Follow us on Twitter
    View our YouTube channel
    Read our LinkedIn profile
    Visit us on Google+
Media Center

California Supreme Court to Review Challenge to "Pay-for-Delay" Agreements That Inflate Prescription Drug Prices by Billions Annually

February 15, 2012

The California Supreme Court today agreed to review whether California's antitrust laws were violated by a nearly $400 million payoff by Bayer Corporation to several generic drug manufacturers for the explicit purpose of preventing the introduction into the market of generic versions of Bayer's antibiotic Cipro.

From 1997 to 2004, Bayer signed exclusionary reverse payment agreements with Barr Laboratories under which Barr agreed not to sell a generic version of Cipro. The agreements allowed Bayer to foreclose competition by sharing its monopoly profits from Cipro with potential competitors. Bayer paid $398.1 million to Barr and other potential competitors who make generic drugs, preserving branded Cipro as the only choice for consumers and thereby maintaining, and even increasing, its cost. Bayer's agreement with generic drug manufacturers to keep generic Cipro off the market was the largest "pay-for-delay deal" of all time. Bayer and the generic companies contend that California's antitrust law does not prohibit such agreements.

The United States Department of Justice, the Federal Trade Commission, California Attorney General Kamala Harris, and numerous other Attorneys General, as well as academics and commentators throughout the country agree that that these types of deals are anticompetitive and should not be permitted.  In particular, California Attorney General Kamala Harris and the American Antitrust Institute submitted letters strongly supporting review of this case, which presents issues of first impression in California.

The four Justices whose names appear on today's order are Justices Kathryn M. Werdegar, Ming W. Chin, Carol A. Corrigan, and Goodwin Liu.

In addition to Lieff Cabraser, Dan Drachler of the Seattle, Washington, law firm Zwerling, Schachter & Zwerling, LLP, and Ralph Kalfayan of Krause, Kalfayan, Benink & Slavens, LLP, located in San Diego, California, serve as counsel for plaintiffs and appellants.

Current Cases